Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Jeffrey L. Silber, MD

Chief Medical Officer
Vedanta Biosciences
Cambridge, Massachusetts, United States

Disclosure(s): Vedanta Biosciences: Employee, Ownership Interest

Presentation(s):

377 - Impact of VE303, a Defined Bacterial Consortium, on Antimicrobial Resistant Gene Prevalence in Patients with Clostridioides difficile Infection (CDI)

Friday, October 18, 2024
1:57 PM – 2:09 PM US PT